Pliant Therapeutics Inc. Company Profile
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pliant Therapeutics at a glance
Pliant Therapeutics Inc. (NASDAQ: PLRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in South San Francisco, CA. Pliant Therapeutics is led by Dr. Bernard Jozef Coulie M.B.A., M.D., Ph.D. and employs about 49 people. The company's shares have traded publicly since 2020.
At a market capitalization of $36.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001746473, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Pliant Therapeutics do?
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Business description based on the company's public filings.
Company information
- Legal name
- Pliant Therapeutics Inc.
- Ticker
- NASDAQ: PLRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Bernard Jozef Coulie M.B.A., M.D., Ph.D.
- Employees
- 49
- Headquarters
- 331 Oyster Point Boulevard, South San Francisco, CA, United States
- Phone
- 650 481 6770
- Website
- pliantrx.com
- IPO year
- 2020
- Market cap
- $36.89M
- SEC CIK
- 0001746473
- Latest annual report
- 10-K · Mar 11, 2026
Companies similar to Pliant Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SDEVStablecoin Development Corporation | 0.50 | -10.30% | $36.90M | vs PLRX |
| GRCEGrace Therapeutics Inc. | 1.71 | -0.58% | $35.97M | vs PLRX |
| CNTBConnect Biopharma Holdings Limited | 0.59 | -6.08% | $38.05M | vs PLRX |
| CUECue Biopharma Inc. | 4.15 | -7.78% | $34.69M | vs PLRX |
| DWTXDogwood Therapeutics Inc. | 1.04 | -2.36% | $39.57M | vs PLRX |
| VERUVeru Inc. | 1.94 | -8.06% | $33.08M | vs PLRX |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.05 | -1.87% | $33.01M | vs PLRX |
| TLPHTalphera Inc. | 0.7852 | +6.25% | $40.80M | vs PLRX |